Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 4/20 | 0.44 |
| ▸ | MMP2 | P08253 | 3/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.39 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | OGT | O15294 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylbarbiturate SCHEMBL31271990 | 0.97 | LMNA (0.46) | LMNAMMP9MMP2PDK2PDK4 | |
| SCHEMBL11278121 | 0.73 | LMNA (0.43) | LMNAMMP9MMP2KDM4EMAPT | |
| SCHEMBL8991935 | 0.73 | LMNA (0.39) | LMNAPDK2PDK4KDM4EMAPT | |
| SCHEMBL12965826 | 0.71 | PDK2 (0.50) | PDK2PDK4KDM4EMAPTRECQL | |
| SCHEMBL3974105 | 0.69 | LMNA (0.46) | LMNAMMP9MMP2KDM4EMAPT | |
| SCHEMBL11173511 | 0.69 | LMNA (0.40) | LMNAMMP9MMP2KDM4EMAPT | |
| SCHEMBL8348835 | 0.69 | LMNA (0.59) | LMNAMMP9MMP2KDM4EMMP13 | |
| SCHEMBL17294203 | 0.67 | MMP9 (0.39) | LMNAMMP9MMP2MAPTMMP13 | |
| SCHEMBL11818576 | 0.67 | LMNA (0.39) | LMNAMMP9MMP2MMP13TP53 | |
| SCHEMBL9591821 | 0.67 | PDK2 (0.71) | LMNAMMP9MMP2PDK2PDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115452747-B | Method for detecting activation degree of cyanogen bromide activated polysaccharide | 艾美探索者生命科学研发有限公司 | 2025-05-20 | — | — | CN | claimed |
| CN-118518606-A | Method for detecting carbodiimide content | 爱美客技术发展股份有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-116879198-A | Method for detecting EDAC residual quantity in crosslinked recombinant collagen anti-blocking film | 浙江诸暨聚源生物技术有限公司 | 2023-10-13 | — | — | CN | claimed |
| WO-2023111869-A1 | METHOD FOR SYNTHESIZING AN ANTI-CANCER COMPOUND THROUGH A ONE-POT REACTION | BATOOIE NASIM (IR) | 2023-06-22 | — | — | WO | claimed |
| EP-3454981-B1 | PALLADIUM CATALYSTS WITH IMPROVED PERFORMANCE IN BIOLOGICAL ENVIRONMENTS | PROMEGA CORP (US) | 2021-03-03 | — | — | EP | claimed |
| US-10882035-B2 | Palladium catalysts with improved performance in biological environments | PROMEGA CORPORATION (US) | 2021-01-05 | — | — | US | claimed |
| EP-3454981-A1 | PALLADIUM CATALYSTS WITH IMPROVED PERFORMANCE IN BIOLOGICAL ENVIRONMENTS | Promega Corporation (US) | 2019-03-20 | — | — | EP | claimed |
| WO-2017196985-A9 | PALLADIUM CATALYSTS WITH IMPROVED PERFORMANCE IN BIOLOGICAL ENVIRONMENTS | PROMEGA CORPORATION (US) | 2018-12-13 | — | — | WO | claimed |
| US-20180029028-A1 | PALLADIUM CATALYSTS WITH IMPROVED PERFORMANCE IN BIOLOGICAL ENVIRONMENTS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2018-02-01 | — | — | US | claimed |
| WO-2017196985-A1 | PALLADIUM CATALYSTS WITH IMPROVED PERFORMANCE IN BIOLOGICAL ENVIRONMENTS | PROMEGA CORPORATION (US) | 2017-11-16 | — | — | WO | claimed |
| US-20150111038-A1 | AMIDES OF 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AND THEIR SALTS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2015-04-23 | — | — | US | claimed |
| EP-2858999-A2 | AMIDES OF 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AND THEIR SALTS | Glenmark Pharmaceuticals S.A. (CH) | 2015-04-15 | — | — | EP | claimed |
| WO-2013183035-A2 | AMIDES OF 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AND THEIR SALTS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2013-12-12 | — | — | WO | claimed |
| US-20130165658-A1 | PROCESS FOR THE PREPARATION OF IODIDES | TECHNION R&D FOUNDATION LTD. (IL) | 2013-06-27 | — | — | US | claimed |
| WO-2011154953-A1 | PROCESS FOR THE PREPARATION OF IODIDES | TECHNION R&D FOUNDATION LTD. (IL) | 2011-12-15 | — | — | WO | claimed |
| US-7863264-B2 | Stabilised compositions having antibacterial activity | COLOPLAST A/S (DK) | 2011-01-04 | — | — | US | claimed |
| WO-2010068789-A1 | POLYETHYLENE GLYCOL-COATED SODIUM CARBONATE AS A PHARMACEUTICAL EXCIPIENT AND COMPOSITIONS PRODUCED FROM THE SAME | TRANSCEPT PHARMACEUTICALS, INC. (US) | 2010-06-17 | — | — | WO | claimed |
| EP-0566289-B1 | Analysis of hemoglobin variants by capillary electrophoresis | BECKMAN INSTRUMENTS INC (US) | 1996-02-07 | — | — | EP | claimed |
| EP-0566289-A1 | Analysis of hemoglobin variants by capillary electrophoresis | BECKMAN INSTRUMENTS, INC. (US) | 1993-10-20 | — | — | EP | claimed |
| US-5202006-A | Using barbituric acid buffer | BECKMAN INSTRUMENTS, INC. (US) | 1993-04-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180029028-A1 | PALLADIUM CATALYSTS WITH IMPROVED PERFORMANCE IN BIOLOGICAL ENVIRONMENTS | PDCD2L, PDCD1, PDCD1LG2 | LMNA 4170/4885MMP9 1784/4885MMP2 1731/4885 |
| US-10882035-B2 | Palladium catalysts with improved performance in biological environments | PDCD2L, PDCD1, PDCD1LG2 | LMNA 4170/4885MMP9 1784/4885MMP2 1731/4885 |
| US-20150111038-A1 | AMIDES OF 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AND THEIR SALTS | AADAC, ABL2, ABL1 | LMNA 4559/4885MMP9 4602/4885MMP2 4372/4885 |
| US-20130165658-A1 | PROCESS FOR THE PREPARATION OF IODIDES | NISCH, TPO, HDHD5 | LMNA 3825/4885MMP9 4251/4885MMP2 2914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.